Kate Kalashnikova

Company: Natera
Job title: Senior Translational Scientist
Seminars:
Clinical Evidence for ctDNA MRD – Where Are We Today and Where Are We Headed? 1:00 pm
• Overview of key clinical evidence supporting the use of ctDNA MRD in identifying patients at high risk of relapse, detecting molecular relapse or progression, and monitoring response to treatment • Top areas of research interest and future opportunities for ctDNA MRD studies, including innovative biomarker analysesRead more
day: Track 1, Day 2 AM